Finance

Lists
ORNAV:HEL
Orion Oyj Class A
€83,00
+0,85%
(+0,70) 1D
13 Okt., 15:36:03 GMT+3  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ORNAV...
Open
€81,90
High
€83,50
Low
€81,90
Mkt. cap
11,75 mjd
Avg. vol.
5,16 k
Volume
6,33 k
Dividend
2,17%
Quarterly dividend
€0,45
Ex-dividend date
15 Okt. 2025
P/E ratio
19,89
52-wk high
€84,40
52-wk low
€56,30
EPS
€4,17
Shares outstanding
31,15 m
No. of employees
4 k
Open
€81,90
High
€83,50
Low
€81,90
Mkt. cap
11,75 mjd
Avg. vol.
5,16 k
Volume
6,33 k
Dividend
2,17%
Quarterly dividend
€0,45
Ex-dividend date
15 Okt. 2025
P/E ratio
19,89
52-wk high
€84,40
52-wk low
€56,30
EPS
€4,17
Shares outstanding
31,15 m
No. of employees
4 k
News stories
From web sources and news partners
Profile
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland. Orion's class A and B shares are listed on the Helsinki Stock Exchange. Wikipedia
About Orion Oyj Class A
CEOLiisa Hurme
Employees4 k
Founded1917
Headquarters-
SectorPharmaceutical industry
Websiteorionpharma.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
423,20 m
695,30 m
417,70 m
521,60 m
Cost of goods sold
169,00 m
186,60 m
163,70 m
181,70 m
Cost of revenue
169,00 m
186,60 m
163,70 m
181,70 m
Research and development expenses
49,80 m
70,60 m
48,30 m
62,20 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
84,60 m
110,30 m
91,90 m
98,90 m
Operating expense
133,20 m
180,40 m
139,30 m
163,40 m
Total operating expenses
302,20 m
367,00 m
303,00 m
345,10 m
Operating income
121,00 m
328,30 m
114,70 m
176,50 m
Other non operating income
-
-500,00 k
100,00 k
-
EBT including unusual items
120,40 m
327,10 m
113,40 m
175,80 m
EBT excluding unusual items
120,40 m
327,30 m
113,40 m
175,80 m
Income tax expense
24,40 m
66,60 m
23,00 m
35,60 m
Effective tax rate
20,27%
20,36%
20,28%
20,25%
Other operating expenses
-1,20 m
-500,00 k
-900,00 k
2,30 m
Net income
96,00 m
260,50 m
90,40 m
140,20 m
Net profit margin
22,68%
37,47%
21,64%
26,88%
Earnings per share
0,68
1,85
0,64
1,00
Interest and investment income
-
4,60 m
-
-
Interest expense
-600,00 k
-5,40 m
-1,40 m
-700,00 k
Net interest expenses
-600,00 k
-800,00 k
-1,40 m
-700,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
135,10 m
336,50 m
130,40 m
191,80 m
Gain or loss from assets sale
-
100,00 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme